Actemra coronavirus clinical trial : Genentech gets FDA nod for COVID-19 trial

pharmanewsdaily- March 24, 2020

Actemra coronavirus clinical trial : Genentech has been given approval by the US Food & Drug Administration (FDA) to undertake the phase 3 COVACTA trial ... Read More

Coronavirus home testing kit launched by US health tech company Nurx

pharmanewsdaily- March 22, 2020

US health tech company Nurx has unveiled a coronavirus home testing kit apart from launching an online coronavirus consultation service to address the COVID-19 pandemic, ... Read More

Health Recovery Solutions launches telehealth COVID-Kit across US

pharmanewsdaily- March 22, 2020

Health Recovery Solutions (HRS), a US-based provider of telehealth and remote patient monitoring solutions, said that its telehealth COVID-Kit is available to all providers. The ... Read More

Gilead Sciences bags Epclusa FDA approval for hepatitis C in pediatric patients

pharmanewsdaily- March 20, 2020

Epclusa FDA approval : Gilead Sciences has secured an expanded approval for Epclusa (sofosbuvir 400mg/velpatasvir 100mg; sofosbuvir 200mg/velpatasvir 50 mg) from the US Food and ... Read More

Polarisqb, Fujitsu join forces to create dengue drug discovery platform

pharmanewsdaily- March 20, 2020

Polarisqb has joined forces with Fujitsu to create a Dengue drug discovery platform that brings together quantum-inspired technology, hybrid quantum mechanics, machine learning, and molecular ... Read More

Japanese group AGC offers €240m bid for Italian biotech company Molmed

pharmanewsdaily- March 18, 2020

Japanese conglomerate AGC has offered a takeover bid of €240 million to acquire 100% of Italian biotech company cum contract development and manufacturing organization (CDMO) ... Read More

First patients being treated with Aimmune’s PALFORZIA peanut allergy drug

pharmanewsdaily- March 17, 2020

Aimmune Therapeutics said that the first patients in the US are being treated with the recently FDA approved peanut allergy drug PALFORZIA . The California-based ... Read More

Coronavirus vaccine trial : Moderna doses first subject with mRNA-1273 in phase 1 trial

pharmanewsdaily- March 17, 2020

Coronavirus vaccine trial : US biotech company Moderna has dosed the first participant in the phase 1 study of mRNA-1273, its mRNA vaccine against the ... Read More

First patients being treated with Aimmune’s PALFORZIA peanut allergy drug

pharmanewsdaily- March 17, 2020

Aimmune Therapeutics said that the first patients in the US are being treated with the recently FDA approved peanut allergy drug PALFORZIA [Peanut (Arachis hypogaea) ... Read More

Thermo Fisher coronavirus diagnostic test gets FDA’s emergency use order

pharmanewsdaily- March 14, 2020

Thermo Fisher Scientific has been granted an emergency use authorization (EUA) for its coronavirus diagnostic test from the US Food and Drug Administration (FDA). The ... Read More